HomeHIMS • NYSE
add
Hims & Hers Health Inc
Previous close
$25.73
Day range
$24.07 - $25.61
Year range
$8.14 - $35.02
Market cap
5.55B USD
Avg Volume
13.93M
P/E ratio
58.74
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 401.56M | 77.13% |
Operating expense | 295.51M | 50.88% |
Net income | 75.59M | 1,098.92% |
Net profit margin | 18.82 | 663.47% |
Earnings per share | 0.43 | 682.40% |
EBITDA | 26.76M | 532.19% |
Effective tax rate | -220.38% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 254.07M | 19.56% |
Total assets | 602.26M | 45.52% |
Total liabilities | 162.21M | 90.16% |
Total equity | 440.05M | — |
Shares outstanding | 218.48M | — |
Price to book | 12.74 | — |
Return on assets | 10.33% | — |
Return on capital | 13.56% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 75.59M | 1,098.92% |
Cash from operations | 85.27M | 238.48% |
Cash from investing | -10.41M | 66.47% |
Cash from financing | -38.82M | -2,390.06% |
Net change in cash | 36.22M | 588.11% |
Free cash flow | 72.52M | 158.41% |
About
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
Hims & Hers operates with a direct-to-consumer model. Consumers consult licensed healthcare professionals and access treatments and products through the company's platform. Customers pay for a consultation with a doctor to prescribe the drug along with the price of the drug itself. The company has expanded its offerings to include health solutions for both men and women, along with mental health services. Wikipedia
Founded
Nov 2017
Headquarters
Website
Employees
1,046